Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2021 Filed Dec 14, 2021 21:15 UTC |
Regan Barry J.EVP Operations
|
SaleCommon Stock | 1,214 | $563.93 | $684,611.02 |
DisclosureSEC source: 0001093557-21-000274 · edgardoc.xml · nonDerivative · entry 1 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,457 F1 · shares: On September 14, 2021, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 11,457 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 00:16 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
SaleCommon Stock | 600 | $517.59 | $310,554.00 |
DisclosureSEC source: 0001093557-21-000272 · edgardoc.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,292 F1 · shares: On June 4, 2021, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,759 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 41 | $569.54 | $23,351.07 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 8 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,597 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $568.675 to $569.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 2 | $567.35 | $1,134.71 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 7 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,638 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $567.295 to $567.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 87 | $565.51 | $49,199.61 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 6 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,640 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $565.13 to $565.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 65 | $564.24 | $36,675.46 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 5 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,727 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $563.83 to $564.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 116 | $562.79 | $65,283.44 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 4 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,792 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $562.48 to $563.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 78 | $561.85 | $43,824.35 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,908 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $561.31 to $561.925. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 70 | $558.78 | $39,114.64 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,986 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $558.40 to $559.14. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 22:53 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 41 | $556.89 | $22,832.49 |
DisclosureSEC source: 0001093557-21-000270 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,056 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 23, 2021 Filed Nov 23, 2021 23:57 UTC |
Stern SadieEVP Chief Human Resources Off
|
SaleCommon Stock | 1,195 | $612.26 | $731,650.70 |
DisclosureSEC source: 0001093557-21-000264 · edgardoc.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,790 F3 · shares: On August 3, 2021, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 11,790 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 23, 2021 Filed Nov 23, 2021 23:51 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 250 | $612.26 | $153,065.00 |
DisclosureSEC source: 0001093557-21-000260 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,579 F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 23:57 UTC |
Stern SadieEVP Chief Human Resources Off
|
SaleCommon Stock | 856 | $638.65 | $546,684.40 |
DisclosureSEC source: 0001093557-21-000264 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,985 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,790 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 23:57 UTC |
Regan Barry J.EVP Operations
|
SaleCommon Stock | 837 | $638.65 | $534,550.05 |
DisclosureSEC source: 0001093557-21-000263 · edgardoc.xml · nonDerivative · entry 1 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,671 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,457 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:12 UTC |
Selvaraj Shelly RamasamySVP Information Technology
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000258 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 F1 · shares: The transaction represents a gift by the Reporting Person of 250 shares to a charitable donor advised fund. F2 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 50 | $654.00 | $32,700.00 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 8 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,705 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 50 | $652.36 | $32,618.00 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 7 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,755 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 878 | $649.02 | $569,837.54 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 6 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,805 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $648.64 to $649.475. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 1,350 | $647.92 | $874,694.70 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 5 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,683 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $647.64 to $648.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 200 | $646.58 | $129,315.00 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,033 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $646.57 to $646.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 250 | $645.01 | $161,251.50 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,233 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $644.99 to $645.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 222 | $644.59 | $143,098.67 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,483 F3 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $643.86 to $644.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 18:11 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000257 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,705 F1 · shares: The transaction represents a gift by the Reporting Person of 3,000 shares to a charitable donor advised fund. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 09, 2021 Filed Nov 11, 2021 00:10 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
GrantCommon Stock | 634 | $634.12 | $402,032.08 |
DisclosureSEC source: 0001093557-21-000254 · edgardoc.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,892 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,759 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| November 03, 2021 Filed Nov 29, 2021 23:36 UTC |
Collins Richard AlexanderDirector
|
SaleCommon Stock | 1,500 | $647.05 | $970,575.00 |
DisclosureSEC source: 0001093557-21-000266 · edgardoc.xml · nonDerivative · entry 1 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 7,204 F1 · date: This Form 4 is being filed late due to an inadvertent administrative oversight and not any error of the reporting person. F2 · ownership.nature: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 40 | $634.01 | $25,360.40 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 11 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,097 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 40 | $631.26 | $25,250.40 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 10 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,137 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 42 | $629.33 | $26,431.86 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 9 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,177 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 76 | $628.41 | $47,758.96 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 8 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,219 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $628.24 to $628.76. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 56 | $627.79 | $35,156.50 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 7 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,295 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $627.045 to $627.91. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 7 | $626.05 | $4,382.32 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 6 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,351 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 124 | $625.32 | $77,539.52 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 5 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,358 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $624.96 to $625.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 43 | $624.10 | $26,836.17 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 4 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,482 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $623.955 to $624.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 13 | $622.63 | $8,094.13 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,525 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 14 | $619.32 | $8,670.48 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,538 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:13 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 45 | $615.13 | $27,680.85 |
DisclosureSEC source: 0001093557-21-000251 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,552 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:12 UTC |
AUGUSTINOS NICHOLASDirector
|
SaleCommon Stock | 2,500 | $600.03 | $1,500,086.75 |
DisclosureSEC source: 0001093557-21-000252 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 F1 · shares: On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $600.00 to $600.295. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 23:35 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 250 | $570.00 | $142,500.00 |
DisclosureSEC source: 0001093557-21-000241 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,829 F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 614 | $555.71 | $341,207.78 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 9 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,705 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F11 · price: This transaction was executed in multiple trades at prices ranging from $555.68 to $556.085. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 350 | $554.73 | $194,154.35 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 8 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,319 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $554.63 to $555.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 200 | $553.14 | $110,628.00 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 7 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,669 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $553.13 to $553.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 851 | $550.93 | $468,838.71 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 6 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,869 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $550.80 to $551.09. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 120 | $549.95 | $65,994.40 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 5 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,720 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $549.73 to $550.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 681 | $548.71 | $373,668.17 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,840 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $548.41 to $549.31. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 939 | $547.76 | $514,343.54 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,521 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $547.395 to $548.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 1,246 | $546.71 | $681,205.02 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,460 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $546.34 to $547.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 23:35 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 999 | $545.84 | $545,294.16 |
DisclosureSEC source: 0001093557-21-000239 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,706 F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $545.25 to $546.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:13 UTC |
Patterson ChadEVP, Global Marketing
|
SaleCommon Stock | 141 | $545.54 | $76,921.14 |
DisclosureSEC source: 0001093557-21-000237 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,603 F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 22:28 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1 | $551.58 | $551.58 |
DisclosureSEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 7 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,597 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 22:28 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 51 | $547.06 | $27,900.00 |
DisclosureSEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 6 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,598 F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $547.00 to $547.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.